Insider Trading March 26, 2026

Interactive Brokers Director Lori Conkling Makes Small Purchases Under 10b5-1 Plan

Two Form 4 filings show $5,390 in Class A stock acquired while IBKR trades near InvestingPro fair value

By Derek Hwang IBKR
Interactive Brokers Director Lori Conkling Makes Small Purchases Under 10b5-1 Plan
IBKR

Interactive Brokers Group director Lori A Conkling reported two purchases of Class A common stock totaling $5,390 executed under a 10b5-1 trading plan, bringing her direct holdings to 2,409 shares. The trades, filed on a Form 4, occurred on February 25 and March 2, 2026. The disclosures follow a period in which Interactive Brokers posted better-than-expected fourth-quarter 2025 results and rolled out new product and market initiatives.

Key Points

  • Director Lori A Conkling purchased 75 shares of Interactive Brokers Class A common stock across two trades totaling $5,390.
  • Transactions were executed under a 10b5-1 trading plan and were not reported immediately due to an oversight; Conkling now directly owns 2,409 Class A shares.
  • Interactive Brokers reported Q4 2025 earnings of $0.65 per share and revenue of $1.64 billion, both beating analyst expectations; BMO Capital raised its price target to $82 and maintained an Outperform rating.

Interactive Brokers Group, Inc. (NASDAQ:IBKR) director Lori A Conkling has reported two small purchases of the company's Class A common stock that together amount to $5,390 in value. The transactions, disclosed on a Form 4 filed with the Securities and Exchange Commission, were carried out under a pre-existing 10b5-1 trading plan and were not initially reported due to an oversight.

According to the filing, Conkling acquired 50 shares on February 25, 2026, at a price of $73.21 per share. She followed up with an additional purchase of 25 shares on March 2, 2026, at $69.21 per share. After these two trades, Conkling directly holds 2,409 shares of Interactive Brokers' Class A common stock.

The reported purchases arrive as Interactive Brokers trades near its InvestingPro Fair Value of $67.70, with the company's common shares quoted at $66.21. The filing notes that the small-scale transactions were executed under the director's 10b5-1 trading arrangement; the delay in reporting was attributed to an oversight.


Contextual corporate updates

Interactive Brokers recently reported its fourth-quarter 2025 financial results, posting earnings per share of $0.65. That figure exceeded the analyst consensus estimate of $0.59 by 10.17%. Revenue for the quarter was $1.64 billion, topping the forecasted $1.61 billion.

Following the earnings release, BMO Capital adjusted its coverage, raising its price target for Interactive Brokers to $82 while maintaining an Outperform rating.

The firm has also expanded its product lineup. Interactive Brokers introduced nano Bitcoin and Ether futures contracts via Coinbase Derivatives, LLC; those contracts are available for trading 24/7 except during scheduled maintenance windows. In the Canadian market, the company launched Registered Retirement Income Funds to provide a retirement drawdown solution for clients.

Separately, Interactive Brokers announced the appointment of Dr. Philip Tetlock to the Board of Directors of ForecastEx, a move the company characterized as strengthening its forecasting and decision-making expertise.


What the filings show

  • Two purchases by Director Lori A Conkling totaling $5,390 in Class A stock.
  • Trades executed on February 25 and March 2, 2026, at $73.21 and $69.21 per share, respectively.
  • Post-transaction direct ownership stands at 2,409 Class A shares.
  • Transactions conducted under a 10b5-1 plan and initially omitted from timely reporting due to oversight.

The filings and corporate updates together provide a snapshot of modest insider buying against a backdrop of better-than-expected quarterly results and recent product and governance developments at Interactive Brokers.

Risks

  • The insider transactions were not initially reported in a timely manner due to oversight, which may raise compliance or disclosure process questions for shareholders - impacting corporate governance scrutiny.
  • Market valuation proximity to InvestingPro Fair Value suggests limited margin between current price ($66.21) and fair value ($67.70), which could influence investor sensitivity to short-term earnings or product announcements - affecting equity market positioning.
  • The reported insider purchases are relatively small in dollar terms ($5,390), which limits their informational weight regarding director conviction or future company performance - reducing potential market impact.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026